Prognostic Factors for Surgical Management of Large Hypertensive Basal Ganglionic Haemorrhage

NCT ID: NCT06309940

Last Updated: 2024-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-31

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to present current and comprehensive recommendations for surgical treatment of this hematoma and to determine the factors that may improve the survival rate

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spontaneous intracerebral hemorrhage is a common, mostly deadly stroke subtype and accounts for 10% to 15% of all strokes.

It's associated with a higher mortality rate (44% after 30 days) than either ischemic stroke or subarachnoid hemorrhage Up to 75% of the long term survivors are often suffering significant disability and only 12% to 39% of the survivors have favourable neurological functions recovered Rapid diagnosis and attentive management of patients is crucial because early deterioration is common Neurosurgical treatment for ICH has been discussed in recent multicentric studies, but no definitive answer of its utility has emerged.

Improved surgical techniques , neuroimaging, neuroanesthesia and perioperative monitoring and care have all led to improved outcomes from surgery

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Basal Ganglionic Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prognostic factors of surgical evacuation of basal ganglionic haemorrhage

Surgical evacuation of basal ganglionic haemorrhage

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\) patients aged between 15 and 60 years old ( elderly people\>60 years were excluded since their strokes weren't routinely examined by CT scan in the emergency ward, however, in children\<15 years old was due mostly to vascular malformations 2) CT scan showed basal ganglionic haemorrhage, with or without intraventricular extension within 24 hr post ictus 3) hematoma volume was 30 ml or above 4) Glasgow Coma Scale scores more than or equal 5 and stable vital signs

Exclusion Criteria

* 1\) intracerebral hemorrhage was caused by secondary factors e.g ( vascular malformations or head trauma) 2) GCS less than 5 or multiple intracranial hemorrhage 3) associated visceral disease e.g hepatic or renal or clotting disorder 4) patients with preexisting neurological deficit e.g previous intracerebral hemorrhage or infarction
Minimum Eligible Age

15 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Sameeh

Resident doctor at neurosurgery Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Farrag Mohamed, Doctor

Role: STUDY_CHAIR

Assiut University neurosurgery Department

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Sameeh, Master

Role: CONTACT

01022690894

Mohamed Abd elbaset, Proffesseur

Role: CONTACT

01006071988

References

Explore related publications, articles, or registry entries linked to this study.

McCarron MO, Nicoll JA. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001 Sep 6;345(10):769; author reply 770. doi: 10.1056/NEJM200109063451014. No abstract available.

Reference Type BACKGROUND
PMID: 11547754 (View on PubMed)

Fernandes HM, Mendelow AD. Spontaneous intracerebral haemorrhage: a surgical dilemma. Br J Neurosurg. 1999 Aug;13(4):389-94. doi: 10.1080/02688699943501.

Reference Type BACKGROUND
PMID: 10616566 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Basal ganglionic haemorrhage

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.